Clinical and Pharmacokinetic Data Support Once-Daily Low-Dose Boosted Saquinavir (1,200 Milligrams Saquinavir with 100 Milligrams Ritonavir) in Treatment-Naive or Limited Protease Inhibitor-Experienced Human Immunodeficiency Virus-Infected Patients

We evaluated the plasma and intracellular pharmacokinetics, clinical efficacy, and safety of once-daily low-dose boosted saquinavir (SQVr; 1,200 of saquinavir [SQV] with 100 mg of ritonavir) plus two nucleotide reverse transcriptase inhibitors in treatment-naive or limited protease inhibitor (PI)-ex...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Marin-Niebla, Ana, Lopez-Cortes, Luis Fernando, Ruiz-Valderas, Rosa, Viciana, Pompeyo, Mata, Rosario, Gutierrez, Alicia, Pascual, Rosario, Rodriguez, Magdalena
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2007
Teme:
Antiviral Agents
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1891384/
https://ncbi.nlm.nih.gov/pubmed/17371813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01136-06
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki